雨课堂学堂在线学堂云Clinical Oncology(吉林大学)单元测试考核答案

目录：第一章货币与货币制度第二章信用与利率第三章金融机构业务与管理第四章金融市场与金融创新第五章金融监管与货币政策调控第1题OnestudyaimedtostudytheassociationofHelicobacterpyloriinfectionandriskofgastriccancer.Theresearchersrecruited500newly-diagnosedgastriccancerpatientsand1000ageandgendermatchednon-cancerindividuals.ThentheresearchersmeasuredtheIgGantibodyofHelicobacterpyloriandtestedwhetherthestatus(positivevsnegative)ofHelicobacterpyloriwasassociatedwiththeriskofgastriccancer.Whatisepidemiologicaldesignofthisstudy?()ACross-sectionalstudyBCase-controlstudyCCohortstudyDClinicaltrialEEcologicalstudy第2题OnestudyaimedtostudytheassociationofHelicobacterpyloriinfectionandriskofgastriccancer.Theresearchersrecruited1000volunteerswithoutgastriccancerandmeasuredtheIgGantibodyofHelicobacterpylori.Thentheresearchersfollowed-upperiodicallythevolunteersfor10yearsandrecordedthecasesofgastriccancer.Afterthefollowing-up,researcherstestedwhetherthebaselinestatus(positivevsnegative)ofHelicobacterpyloriwasassociatedwiththedevelopmentofgastriccancer.Whatisepidemiologicaldesignofthisstudy?()ACross-sectionalstudyBCase-controlstudyCCohortstudyDClinicaltrialEEcologicalstudy第3题OnestudyaimedtostudywhethereradicationofHelicobacterpyloricouldreducetheriskofgastriccancer.Theresearchersrecruited2000Helicobacterpylori–positivevolunteerswithoutgastriccancer,andthengroupedthemrandomlytotheinterventiongroup(receivingtreatmentofHelicobacterpylori)andtothegroupwithouttreatment.Thentheresearchersfollowed-upthevolunteersperiodicallyfor10yearsandrecordedthecasesofgastriccancer.Afterthefollowing-up,researcherstestedwhetherthebaselineinterventionwasassociatedwiththedevelopmentofgastriccancer.Whatisepidemiologicaldesignofthisstudy?()ACross-sectionalstudyBCase-controlstudyCCohortstudyDExperimentaltrialEEcologicalstudy第4题OnestudyaimedtostudythedistributionofHelicobacterpyloriinfectioningeneralpopulation.Theresearchersselectedthesubjectsincommunitiesofonedistrictusingaprobability-basedsamplingdesign,andmeasuredtheinfectionstatusofHelicobacterpylori.Whatisepidemiologicaldesignofthisstudy?()ACross-sectionalstudyBCase-controlstudyCCohortstudyDClinicaltrialEEcologicalstudy第5题OnestudyaimedtostudytheassociationofHelicobacterpyloriinfectionandriskofgastriccancer.Theresearchersrecruitednewly-diagnosedgastriccancerpatientsandnon-cancercontrolsandthendeterminedthestatus(positivevsnegative)ofHelicobacterpylori.Theyfoundthatcomparingtothecontrols,HelicobacterpylorihasanOR1.8(P<0.05).Whichofthefollowingsisnottrue?()AThepositiverateofHelicobacterpyloriishigherinthegastriccancergroup.BHelicobacterpyloriisassociatedwith1.8timeshigherriskofgastriccancer.CHelicobacterpyloriisariskfactorforgastriccancer.DThecontrolgrouphashigherriskofHelicobacterpylori.EThisisacasecontrolstudydesign.第1题Whatarethetopthreemodifiableriskfactorsfordevelopingcancer?()ATobaccouse,excessbodyweight,alcoholintakeBTobaccouse,sun/UVexposure,alcoholuseCTobaccouse,cancer-causingpathogens,physicalinactivityDTobaccouse,sun/UVexposure,excessbodyweightETobaccouse,physicalinactivity,sun/UVexposure第2题Themostrecentestimateisthat13percentofallnewcancercasesdiagnosedworldwidewereattributabletopersistentinfectionwithpathogens.Whichofthefollowingisthemostcommoncancer-causingpathogen?()AHelicobacterpyloriBHepatitisBvirus(HBV)CHepatitisCvirus(HCV)DHumanpapillomavirus(HPV)EAlloftheabove正确答案：E第3题Changingormodifyingcertainbehaviorscanreduceriskfordevelopingcancer.Whichofthefollowinglifestylemodificationscanreduceriskofcancer?()AStayphysicallyactiveBLimitconsumptionofredmeatandprocessedfoodsCMaintainahealthy(lean)weightDLimitalcoholconsumptionEAlloftheabove正确答案：E第4题Whatis

not

asignificantfactorincreasingthelikelihoodofdevelopingovarianandbreastcancers?()ABRAC1orBRAC2mutationsBHavingachildaftertheageof30CSmokingDHormonereplacementtherapyEBeingoverweightfollowingmenopause第5题A39-year-oldwomancomestothephysicianbecauseofmildclumsinesswhenwalking,tinglinginherhandsandfeet,andpersistentfatigue.Shestatesthatshemaintainsthesamebalanceddiet.Hertemperatureis36.9°C(98.4°F),pulseis80beatsperminute,respirationsare14aminute,andbloodpressureis128/76mmHg.Physicalexaminationshowsasmooth,redtonguewithlossofpapillae,mildgaitdisturbance,andimpairedpositionsenseandvibrationperception.Laboratorytestsshowanerythrocytecountof3.0million/mm3,hemoglobinof10g/dL,hematocritof30%,andMCVof125mum3.Serumfolatelevelisnormalandserummethylmalonicacidiselevated.OralvitaminabsorptionstudiesdemonstratethatthepatientisunabletoabsorbvitaminB12

inadequateamountswithoutaddedintrinsicfactor.Thispatient'sconditionisassociatedwithanincreasedriskofdevelopingcancerofwhichofthefollowingorgans?()AColon.BDuodenum.CEsophagus.DIleum.EStomach.正确答案：EMolecularmechanismsoftumorigenesistask第1题Whichofthefollowingisnotaninactivationmechanismoftumorsuppressorgenes:()AGenemutationBLossofheterozygosityCGeneamplificationDEpigeneticabnormalities第2题Whichofthefollowingisnotaconsequenceofgeneamplification?()AExcessiveDNAreplicationBGenemutationCGenecopynumberincreaseDProteinencodedincrease第3题Chromosometranslocationcanmakeaproto-oncogeneunderthecontrolof:()AAstrongpromoterBAnintronCAnexonDAnenhancer第4题The3stepsofsignaltransductioninorderare()AReception,Transduction,ResponseBResponse,Reception,TransductionCTransduction,Reception,ResponseDTransduction,Response,Reception第5题WhichofthefollowingplaysakeyroleinaberrantactivationofPI3K-AKTsignalingpathway:()ADeletionofPI3KCABAmplificationofEGFRCAmplificationofPTENDMutationofPDK1第6题Whichofthefollowingstatementisincorrect:()AThecoreelementofsignalingpathwaycontainsligand,receptor,transductionmolecule,andtranscriptionfactorBCancercellsacquirenovelsignalingpathwaystomaintaintheirconstantproliferationCVarioussignalscanbetransducedthroughthesamedownstreameffectorDOnesignalisusuallytransducedthroughmultipledownstreameffectorsBiologicalbehavioroftumorigenesistask第1题Whichofthefollowingisnotpro-angiogeniccytokines:()AVascularendothelialcellgrowthfactor(VEGF)BAngiogenin(Ang)CFibroblastgrowthfactors(FGF)DMatrixmetalloproteinase(MMP)EInterferon(INF)正确答案：E第2题What’sthemechanismofVEGFparticipateinthewholeprocessoftumorgrowth,choosethebestanswer?()APromoteangiogenesisBFormabnormalvesselsCIncreasevascularpermeabilityDPromotemetastasisEAlloftheabove正确答案：E第3题Whatarethemainfeaturesofmalignanttumors?()AInvasionandmetastasisBInfiniteproliferationandexfoliationCWarburgeffectandangiogenesisDImmuneescapeandarrestedapoptosisEGenomeinstabilityandmutation第4题Whatisnecessaryatthebeginningandendoftumormetastasis:()AAngiogenesisBEnterthecirculatorysystemCShedandinvadedintothematrixDTumorthrombusformationETumorcellsgrowatthesecondarysites第5题Cyclinisassociatedwith___________()ALeptospirosisBGlycolysisCCytosisDMitosisENoneoftheabove第6题Cdksbindwith__________,enablingtheCdkstofunctionasenzymes.AMPFBCyclinsCHistonesDP53EEF1第7题Whichofthefollowingisnottumorsuppressorprotein?()AP53BP16CBCL2DRbEAPC第8题Whichofthefollowingphasesismostsensitivetoradiotherapy？AG0BG1/S

CG1DSEG2/M正确答案：ETumormarkerdiagnosistask第1题Theroleoftumormarkersdoesnotinclude()AJudgementoftumorprognosisBIndividualizedtreatmentoftumorCEarlydetectionoftumorDMonitoringoftumortreatmentefficacyEDiagnosticindicatorsoftumor正确答案：E第2题Whichofthefollowingistheindicatortoguidethemoleculartargetedtherapyofbreastcancer()ACEABEGFRCHer-2DK-RASEALK第3题Whichofthefollowingisnotacharacteristicofanidealtumormarker()AGoodorganspecificityBHighsensitivityCEasytodetectDLonghalf-lifeEItisrelatedtothemalignantdegreeandprognosisofthetumor第4题Whichofthefollowingtumormarkersisoftenusedforbreastcancer()ACA153BPSACNSEDCA72-4EAFP第5题Whichofthefollowingtumormarkerscanguidetheendocrinetherapyofbreastcancer（）ABRAFBER、PRCEGFRDCA153EHer-2第6题Whichofthefollowinggenemutationspredictsanincreasedriskofbreastcancer（）AHer-2BKRASCBRCA1、BRCA2DEGFREER、PRPathologicaldiagnosisoftumortask第1题Generallywenamethebenigntumorswithhistologicaloriginplus–oma,exceptfor_____().AAdipomaBFibromaCAdenomaDMelanomaELeiomyoma第2题WhichofthefollowingisNOTture?

(___)ABenigntumorscanchangeintomalignanttumors.BMalignanttumorscanstoptogrowwithoutanyintervention.CAccordingtodifferentiation,atypia,mitosis,etc.wegradetumorsintowelldifferentiated,moderatedifferentiatedandpoordifferentiated.DNomenclatureoftumorscancombineclinical,pathologicalmorphologic,immunohistochemicalphenotypicalandmoleculargeneticcharacteristics.ETumorscanbeclassifiedintobenign,borderlineandmalignantaccordingtothecharactersandharmtothehumanbody.第3题Thetumorswhosenamesendedwith–blastomausuallyaremalignant,exceptfor_____().ANeuroblastomaBOsteoblastomaCHepatoblastomaDRetinoblastomaENephroblastoma第4题Whichofthefollowingplaysakeyroleindifficultiesofpathologicaldiagnosis?(___)ASpecimenBFixationCDissectionDDiagnosticexperienceEAlloftheabove正确答案：E第5题A3-year-oldfemalepatientwasadmittedinthehospitalforpresenceofabdominalmass(maximumdiameter:10.5cm).Initialbiopsypathologicaldiagnosiswasganglioneuroma.However,afterexcisionofabdominalmassfinaldiagnosisbecameganglioneuroblastoma.Whichofthefollowingshouldberesponsibleforthesituation?(___)()AThelimitationofbiopsyspecimenBThebiopsyspecimenisnotwellfixed.CThepathologicalmedicianislackofdiagnosticexperienceDTumorheterogeneityEThelesionstillhasnotprogresstothetypicalmorphorlogy.Imagingdiagnosisoftumortask第1题Keypointsforclinicaldiagnosisofprimarylivercancer,thefollowingoptionsarenotincluded:()AHistoryofHBVorHCVBHepaticmassCAFP>400ug/lfor1monthorAFP>200ug/lfor2monthsDAbdominalvarices,splenomegalyEImagingevidenceofB-ultrasoundandCTexamination第2题WhichoftheCTfindingsofprimarylivercanceriswrong:()AEnhancedscanshowedobviousenhancementinvenousphaseBMostoftheplainscanswerelow-densityfociCEnhancedscanningshowedobviousenhancementinarterialphaseDLocallivercontourmaybeconvexEWithcirrhosisandsplenomegaly第3题WhichiswrongabouttheconceptofCTplainscanforlivercancer:()AMostlesionswerelowdensityBInfattyliverorcirrhosis,thedensitydifferencebetweentheliverandthefocusdecreasesCThebetterthedifferentiationoftumorcells,thegreaterthedifferencebetweentheirdensityandthatofnormalliverDWithnecrosis,hemorrhageandcalcificationEWhenfattyliverisparticularlyprominent,thelesionbecomeshigherdensity第4题MRIfindingsofnormallivercancer:()AThesignalofT1weightedimageishigherthanthatofspleen,andthesignalofT2weightedimageislowerthanthatofspleenBThesignalofT1weightedimageislowerthanthatofspleen,andthesignalofT2weightedimageishigherthanthatofspleenCT1andT2weightedimagesignalswerehigherthanthoseofspleenDT1andT2weightedimagesignalswerelowerthanthoseofspleenET1andT2weightedimagesignalsweresimilartothoseofspleen第5题Whichofthefollowingiswronginangiographicfindingsofprimarylivercancer:()ACompressionanddisplacementofpericancerousarteriesBNeovascularizationandtumorstainingCPortalveininvasionandtumorthrombusformationDOcclusionofbloodsupplyarteryEArteriovenousfistulaClinicalDiagnosisandtreatmentevaluationoftumorstask第1题Whichofthefollowingstatementsisfalse?()ATheTNMstagingsystemhasbeenwidelyusedintheevaluationofhematologicaltumors.BTNMstagingcriteriaaredifferentindifferenttumors.CTheTstagingrepresentsthesizeofthetumour.DTheNstagingrepresentsthelymphnodeinvasion.ETheMStagingrepresentsthemetastasisoftumour.第2题()representsfailuretoassesstheprimarytumor.ATxBTisCT0DT1ET2第3题Whichofthefollowingstatementsistrue?()ARelapsestagingshouldbeestablishedbeforethebeginningofanyanticancertreatmentandshouldnotbealteredbasedonanydataobtainedaftertreatment.BClinicalstagingisbasedontheevidenceobtainedbeforetheinitialtreatment.CClinicalstagingissupplementedandrevisedaccordingtootherevidenceobtainedfromsurgery(especiallyevidencefrompathologicaldiagnosis).DPathologicalstagingismoreimportantthanclinicalstagingandhasreplacedclinicalstagingintheevaluationoftumourtreatment.EClinicalstagingisbasedontheevidenceobtainedaftertheinitialtreatment.第4题Whichofthefollowinglesionismeasurable?()ApericardiumascitesBLeptomeningealmetastasisCInflammatorylymphaticmetastasisinskinorlungDFusionnodes.第5题Therequirementsformeasurement,except:()AThebaselinetimeshouldbeclosetothebeginning,lessthan4weeks.BForthesamelesion,thesameexaminationmethodwasusedatbaselineandfollow-up.CTendtothesamemeasuringphysician.DNumber:eachorgan≤2,total≤10.第6题Howtodefineprogressiondisease?()AAtleasta20%increaseinthesumofdiametersoftargetlesionscomparedwithminimum,thesummustalsodemonstrateanabsoluteincreaseofatleast5mm.Orappearanceofnewlesions.BAtleasta20%increaseinthesumofdiametersoftargetlesionscomparedwithbaseline,thesummustalsodemonstrateanabsoluteincreaseofatleast5mm.Orappearanceofnewlesions.CAtleasta20%increaseinthesumofdiametersoftargetlesionscomparedwithminimum,thesummustalsodemonstrateanabsoluteincreaseofatleast10mm.Orappearanceofnewlesions.DAtleasta20%increaseinthesumofdiametersoftargetlesionscomparedwithbaseline,thesummustalsodemonstrateanabsoluteincreaseofatleast10mm.Orappearanceofnewlesions.Comprehensivetherapyandindividualtherapyoftumor第1题Whichofthefollowingstatementsisincorrect:()AMolecularmarkersmainlyincludeprognosticandpredictivemolecularmarkersBPrognosticmarkersareassociatedwithdiseaseoutcomeCPrognosticmarkersarerelatedtotherapeuticdrugsandotherinterventionsDPredictivemarkersarefactorsthatcanjudgetheprobabilityoftreatmenteffectEPredictivemarkersarerelatedtotherapeuticdrugsandotherinterventions第2题Themostcommontargetofnon-smallcelllungcanceris:()AHER2BEGFRCBCR/ABLDBRAFV600EEKIT第3题Thebasicprincipleofcancercomprehensivetreatment:()APayingequalattentiontobothlocalandwholebody,costandeffect,andsurvivalandqualityoflifeBTreatmentbystagesCIndividualizedtreatmentDWholeprocessmanagementEAlltheabove正确答案：E第4题Themosteffectivelocaltreatmentforcanceris:()ARadiotherapyBSurgicaltreatmentCVascularinterventionaltherapyDNon-vascularinterventionaltherapyEOthertreatment第5题Themostwidelyusednon-surgicalcomprehensivetreatmentmodeforcanceris:()ASequentialtherapyBSimultaneoustherapyCAlternativetherapyDTraditionalChinesemedicineERehabilitationandpalliativetreatment第6题Whichofthefollowingisnotcommonlyusedasanembolizationagent:()ADoxorubicinBSpringcoilCGelatinSpongeDPVAparticlesEIodizedoil第7题ForTACE,themostcommonarterytopunctureis()AFemoralveinBFemoralarteryCIliacarteryDIliacveinE.Thehepaticartery第8题WhichofthefollowingisnotanindicationforTACEsurgery()AThemainportalveinisnotcompletelyobstructedBThegoalofpreoperativetreatmentistoshrinkthetumorforsecondarysurgeryCLiverfunctionisinChildCDThepatientcannotbeexcisedforvariousreasonsordoesnotreceivesurgicaltreatmentEPostoperativerecurrence正确答案：ESurgicaltreatmentoftumortask第1题InWhipple’soperation,weneedtoremovethefollowingorgans,except()ADuodenalruptureBTheGDACHelendidDSpleenEBileduct第2题IfICGR15between10%and19%,()A4segmentsofliveraretoleratedBonly1segmentofliveristoleratedC2or3segmentsofliveraretoleratedDonlytumorenucleationElocalizedminorhepatectomy第3题Surgeryisthemosteffectivetreatmentforsolidtumors,()%ofthetumorsweretreatedsurgicallyA10B20C30D60E90第4题Whichbloodvesseldoesnotcomefromtheabdominaltrunk()ASplenicarteryBLefthepaticarteryCRighthepaticarteryDGDAEPortalvein正确答案：E第5题WhoneedstoacceptWhipple’soperation()ALungCancerBLiverCancerCRectalCancerDPancreaticheadcancerEEsophagealCancerRadiationoncologytask第1题TheyearwhenRoentgendiscoveredX-raysis:()A1885B1886C1898D1895E1902第2题TheyearwhenMarieCuriediscoveredradiumis:()A1885B1886C1897D1895E1902正确答案：E第3题Theconventionalfractionateddoseofradiotherapyis:()A3.5-4.0Gy

B1.5-1.8GyC1.0-1.2GyD2.8-3.0GyE1.8-2.0Gy

正确答案：E第4题ThemostimportanttargetofX-raykillingcellsis:()ADNABRNACCellmembranesDMitochondriaEProteins第5题Themostsensitivecellcyclephasetoradiationis:()AG0BG1CG2/MDSESameradiosensitivityforallphasesabove第6题Whichofthefollowingoptionsisnotpartofthe"4Rs"theoryofradiobiology:()ARadiationdamageBRedistributionofcellcycleCReoxygenationofhypoxiccellsDApoptosisafterirradiationERepopulationofcellsChemotherapyoftumortask第1题WhichofthefollowingdrugisanRNA-blockingdrug：（）APlatinumBDaunorubicinCCyclophosphamide

DIrinotecanEGemcitabine第2题Whichofthefollowingisacommonlong-termtoxicsideeffectofchemicaldrugs:()AMyelosuppressionBGastrointestinalreactionsCAlopeciaDSecondarytumorsENeurotoxicity第3题Whichofthefollowingisnottheapplicationprinciplesofchemotherapydrugs:()AAppropriatemedicationtimeBMaximumdrugdoseCMulti-cycletherapyDCombinationchemotherapyEAppropriateadministrationroute第4题Whichofthefollowingdrugexertsantitumoreffectsbyinhibitingtopoisomerase:()AEtoposideBVincristineCPaclitaxelDDocetaxelEPlatinum第5题WhichofthefollowingdrugactsontheG1phaseofthecellcycle:()AAsparaginaseBFluorouracilCEtoposideDVinblastineEPaclitaxel第6题Nauseaand/orvomitingareadverseside-effectsofcancerchemotherapeuticdrugsinadult.Nauseaandvomitingarenotonlyexperiencedasposttreatmentsymptomsafterchemotherapy.Inwhichsubgroupofvomitingtypes,thesesymptomsalsooccurpriortoachemotherapeuticdruginfusion.()AAcutevomitingBDelayedvomitingCAnticipatoryvomitingDBreakthroughvomitingERefractoryvomiting第7题AccordingtoCommonTerminologyCriteriaforAdverseEvents(CTCAE）v5.0,whichofthefollowingisagrade3adversereaction.()ANeutrophils＜500/microLBPlatelets25,000/microLto50,000/microLCHemoglobins8.0to10.0g/dLDNeutrophils＜500/microLwithasingletemperature＞38.5℃EPlatelets＜25,000/microLInterventionaltherapyoftumortask第1题Whichofthefollowingtypesbelongstolocalablationtherapy,except：()Amicrowaveablation(MWA),

Btrans-arterialchemoembolization(TACE)Cpercutaneousethanolinjection(PEI)Dhigh-intensityfocusedultrasoundablation(HIFU)Efrequencyablation(RFA)第2题Themostcommonlyusedguidancemethodformicrowaveablationtherapyis（）ACTBMRICUSDECG

EPET-CT第3题Aftermicrowaveablation,thegrosspathologicappearanceoftreatedtissueshouldbereferredto()ACaseousnecrosisBLiquefactionnecrosisCHydropicdegenerationDFattydegenerationECoagulationnecrosis正确答案：EBiotherapyoftumortask第1题Whichofthefollowingdoesnotfallwithinthescopeofbiotherapyforcancer:()AImmunotherapyBTargetedtherapyCRadiationtherapyDEndocrinetherapyEGenetherapy第2题Whichofthefollowingisnotabiologicalreactionregulator:()ACytokinesBCisplatinCTNF-αinhibitorsDMonoclonalantibodyEApatinib第3题Whichofthefollowingisnotspecificimmunotherapy:()ATumorvaccineBRituximabmonoclonalantibodyCTILtherapyDNKcelltherapyECAR-Ttreatment第4题Whichofthefollowingdrugshastheeffectofinducingdifferentiation:()AArsenictrioxideBBortezomibCCetuximabDTamoxifenEInterleukin第5题Whichofthefollowingdrugsisnotamoleculartargetedtherapy:()ATrastuzumabBIcotinibCColonystimulatingfactorDImatinibEBevacizumabTargetedtherapyoftumortask第1题Whichofthefollowingdrugsisnotmoleculartargetedtherapydrug?ACetuximabBBevacizumabCTrastuzumabDPembrolizumabEGefitinib第2题Whichofthefollowingdrugsisasmallmoleculetargeteddrug?ABevacizumabBPertuzumabCSorafenibDRituximabEPanitumumab第3题Whichofthefollowingdrugsdon‘tbelongtyrosinekinaseinhibitors?AgefitinibBsunitinibCdasatinibDbevacizumabEsorafenib第4题Whichofthefollowingdrugismoleculartargetedtherapydrug?APanitumumabBBevacizumabCTrastuzumabDGefitinibEAllabove正确答案：E第5题Whichmechanismistargetingtumorgrowthmicroenvironment?ACellepigeneticsBAnti-angiogenesisCApoptosisfactorsDIntracellularsignaltransductionmoleculesEGrowthfactorreceptorsandcellmembranedifferentiationantigensonthecellmembraneImmunotherapyofcancertask第1题Themainmechanismofanti-tumorimmunityis()ANon-specificanti-tumoreffectofNKcellsBAntitumoreffectofnon-specificimmunecomponentsinbodyfluidsCCellularimmunityDHumoralimmunityETumorkillingeffectofTILandLAKcells正确答案：E第2题Antitumormechanismsofantibodiesdonotinclude()ACDCBADCCCOpsonizationDAntibodiesblockcertainreceptorsontumorcellsEBlockingtheeffectofcytokines正确答案：E第3题Whichofthefollowingisnotconsideredpassiveimmunotherapyfortumors()ADNAvaccineBTNFCTILcellDExogenousimmuneeffectorENKcell第4题ThefollowingsaredescriptionsofNKcellkilling,whichiswrong()ALackspecificityBDirecttumorkillingwithoutprioractivationCAntibody-dependentkillingoftumorsbyADCCDComplement-dependentkillingoftumorsbyCDCENoMHCrestriction第5题Whichofthefollowingisnotintendedtotreatcancerthroughregulatingtheimmunesystem:()AEnhancesimmunityagainsttumorBSuppressimmunosuppressivecheckpointsCImprovingtumorsuppressivemicroenvironmentDBreakingimmunetoleranceEBlockingTcellactivationbytargetingcostimulatorymolecule正确答案：E第6题Toavoidoveractivation,whichofthefollowingmoleculescanTcellsexpress:()APD-1BPD-L1CTCRDMHC-IIEICOS第7题Whichofthefollowingisnotanimmunecheckpointinhibitor:()APD-1antibodyBPD-L1antibodyCCTLA-4antibodyDCD20antibodyENKG2Aantiboy第8题Whichofthefollowingisnotacommonsideeffectofimmunecheckpointinhibitors:()AEnteritisBHypophysitisCSkinRashDVitiligoETumorlysissyndrome正确答案：E第9题Whichofthefollowingistumor-specificphenomenawithimmunecheckpointinhibitors:()APrimarydrugresistanceBAcquireddrugresistanceCSuper-progressionDTumorprogressionETumorregression第10题ThebasiccharacteristicsofchimericantigenreceptorTcelltherapy,except:()AMHC-restrictedBCAR-TtherapyisakindofadoptivecelltherapyCThemainsideeffectsincludecytokinereleasesyndromeandimmuneeffectorcell–associatedneurotoxicitysyndromeDneedtobindspecificsurfaceantigenontumorcellsECARshavebeendesignedusingreceptors,ligands,orscFvbindingdomains18.Cancerpaintherapytask第1题Whichofthefollowingisnotthecauseofcancerpain:()ATumorinvadesnerveBIntercostalnervepainafterlungcancersurgeryCHerpeszosterneuralgiaafterchemotherapyforlungcancerDPainaftertraumaEPleuriticpainafterradiotherapyforlungcancer第2题Whichofthefollowingisnotacancerpainassessmentprinciple:()ARegularBTakestheinitiativeCQuantizationDComprehensiveEDynamic第3题Amongthequantitativeassessmentmethodsofcancerpain,themostsuitableassessmentmethodforchildren,theelderlyandcommunicationdisorders:()ANRSBWongBakerCVASDVRSEBPI第4题Inthequantitativeassessmentmethodofcancerpain,whichisseverepainis:()ASleepismildlydisturbedBHaspainandcanliveanormallifeCSleepisnotdisturbedDSleepisoccasionallydisturbedESeverelydisturbedsleep正确答案：E第5题CancerpainassessmentNRSmethodbelongstoseverepainis:()A8B2C3D6E12第6题Whichofthefollowingisnotacancerpaintreatmentmethod:()AAntitumortherapyBOpioidtherapyCInterventionaltherapyDAntibiotictreatmentENSAIDtherapy第7题Whichofthefollowingdoesnotbelongtothethree-steptreatmentprincipleis:()AOraladministrationBDosingbyladderCDosingontimeDOn-demandadministrationEIndividualizeddrugdelivery第8题Inthethree-steptreatmentprincipleofcancerpain,severepainshouldbegiven:()ASingleuseofCelebrexBPregabalinaloneCCelebrex+PregabalinDTramadol+PregabalinEOxyContinorOxyContin+Celebrex正确答案：E第9题Whichofthefollowingarestrongopioidsis:()AFentanylBCelebrexCDexamethasoneDCodeineEPregabalin第10题Themostcommonlyusedmethodofadministrationaccordingtothethree-steptreatmentprincipleofcancerpainis:()ASubcutaneousBOrallyCVeinDIntramuscularinjectionEMucosaNutritiontherapyofcancertask第1题Whichofthefollowingstatementsisfalse?()ANutritionalsupportcanbegivenacrossthestepBEnteralnutritionsupplementationtakesprecedenceoverparenteralnutritionCNutritionalsupportshouldfollowindividualizedprinciplesDTwointolerancesmayoccurduringtotalenteralnutritiontherapy:gastricintoleranceandintestinalintoleranceEForpatientswithGItumors,parenteralnutritionshouldbepreferred正确答案：E第2题Nutritionalassessmentshouldbecompletedwithin()ofthepatient'sadmissionandperformedbyanutritionnurse,dietitianorphysician:()A24HoursB48HoursC14HoursD6HoursE36Hours第3题Whichofthefollowingisanutritionalinterventionthatallpatientswithmalnutrition(exceptthosewhocannotconsumefoodorally)shouldreceive:()AGastroenterostomyBjejunostomytubeCParenteralnutritionsupportDDiet+NutritionEducationEnone第4题IntheeventthattheTENdoesnotmeettherequirement,thechoiceshouldbe:()APEN+PPNBPENCPPNDONSEDiet+NutritionEducation第5题WhichofthefollowingisnotanindicationforTPN?()ALossofdigestivetractfunctionBNeedforintestinalrest:whenenteralnutritionc